William Blair Issues Positive Outlook for NMRA Earnings
Neumora Therapeutics, Inc. (NASDAQ:NMRA – Free Report) – Equities researchers at William Blair increased their Q1 2025 earnings per share (EPS) estimates for shares of Neumora Therapeutics in a report released on Monday, March 3rd. William Blair analyst M. Minter now expects that the company will post earnings per share of ($0.37) for the quarter, […]
